{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:28:53Z","timestamp":1775082533456,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":3425,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s13311-013-0255-9","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T13:20:14Z","timestamp":1391001614000},"page":"433-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Chronic Treatment with 17-DMAG Improves Balance and Coordination in A New Mouse Model of Machado-Joseph Disease"],"prefix":"10.1016","volume":"11","author":[{"given":"Anabela","family":"Silva-Fernandes","sequence":"first","affiliation":[]},{"given":"Sara","family":"Duarte-Silva","sequence":"additional","affiliation":[]},{"given":"Andreia","family":"Neves-Carvalho","sequence":"additional","affiliation":[]},{"given":"Marina","family":"Amorim","sequence":"additional","affiliation":[]},{"given":"Carina","family":"Soares-Cunha","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Kenneth","family":"Thirstrup","sequence":"additional","affiliation":[]},{"given":"Andreia","family":"Teixeira-Castro","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Maciel","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"11","key":"10.1007\/s13311-013-0255-9_bib1","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/archneur.58.11.1821","article-title":"Improvement in the molecular diagnosis of Machado-Joseph disease","volume":"58","author":"Maciel","year":"2001","journal-title":"Arch Neurol"},{"issue":"7","key":"10.1007\/s13311-013-0255-9_bib2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1212\/WNL.28.7.703","article-title":"Autosomal dominant system degeneration in Portuguese families of the Azores Islands. A new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions","volume":"28","author":"Coutinho","year":"1978","journal-title":"Neurology"},{"issue":"4","key":"10.1007\/s13311-013-0255-9_bib3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00401-010-0717-7","article-title":"Axonal inclusions in spinocerebellar ataxia type 3","volume":"120","author":"Seidel","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1007\/s13311-013-0255-9_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0896-6273(00)80943-5","article-title":"Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3","volume":"19","author":"Paulson","year":"1997","journal-title":"Neuron."},{"issue":"Pt 7","key":"10.1007\/s13311-013-0255-9_bib5","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/brain\/awr146","article-title":"Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor","volume":"134","author":"Huang","year":"2011","journal-title":"Brain"},{"issue":"5","key":"10.1007\/s13311-013-0255-9_bib6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1460-9568.2010.07352.x","article-title":"Levels of DNAJB family members (HSP40) correlate with disease onset in patients with spinocerebellar ataxia type 3","volume":"32","author":"Zijlstra","year":"2010","journal-title":"Eur J Neurosci"},{"issue":"23","key":"10.1007\/s13311-013-0255-9_bib7","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1523\/JNEUROSCI.19-23-10338.1999","article-title":"Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease","volume":"19","author":"Chai","year":"1999","journal-title":"J Neurosci"},{"issue":"3","key":"10.1007\/s13311-013-0255-9_bib8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.nbd.2008.10.016","article-title":"In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis","volume":"33","author":"Williams","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1007\/s13311-013-0255-9_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/nbdi.2002.0502","article-title":"Chemical chaperones reduce aggregate formation and cell death caused by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch","volume":"10","author":"Yoshida","year":"2002","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10.1007\/s13311-013-0255-9_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/70532","article-title":"Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70","volume":"23","author":"Warrick","year":"1999","journal-title":"Nat Genet"},{"issue":"6","key":"10.1007\/s13311-013-0255-9_bib11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.phrs.2012.10.002","article-title":"Chaperones in autophagy","volume":"66","author":"Kaushik","year":"2012","journal-title":"Pharmacol Res"},{"key":"10.1007\/s13311-013-0255-9_bib12","doi-asserted-by":"crossref","first-page":"736905","DOI":"10.1155\/2012\/736905","article-title":"Aggrephagy: selective disposal of protein aggregates by macroautophagy","volume":"2012","author":"Lamark","year":"2012","journal-title":"Int J Cell Biol."},{"issue":"4","key":"10.1007\/s13311-013-0255-9_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0092-8674(00)81588-3","article-title":"Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1","volume":"94","author":"Zou","year":"1998","journal-title":"Cell"},{"issue":"4","key":"10.1007\/s13311-013-0255-9_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/152165499306829","article-title":"Geldanamycin induces heat shock protein expression through activation of HSF1 in K562 erythroleukemic cells","volume":"48","author":"Kim","year":"1999","journal-title":"IUBMB Life"},{"issue":"13","key":"10.1007\/s13311-013-0255-9_bib15","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/hmg\/ddh144","article-title":"Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach","volume":"13","author":"Hay","year":"2004","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1007\/s13311-013-0255-9_bib16","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/hmg\/10.12.1307","article-title":"Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease","volume":"10","author":"Sittler","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1007\/s13311-013-0255-9_bib17","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1074\/jbc.M412106200","article-title":"Mechanisms of suppression of {alpha}-synuclein neurotoxicity by geldanamycin in Drosophila","volume":"280","author":"Auluck","year":"2005","journal-title":"J Biol Chem"},{"issue":"15","key":"10.1007\/s13311-013-0255-9_bib18","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1093\/hmg\/ddr203","article-title":"Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1 pathways","volume":"20","author":"Teixeira-Castro","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.1007\/s13311-013-0255-9_bib19","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm1298","article-title":"17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration","volume":"11","author":"Waza","year":"2005","journal-title":"Nat Med"},{"issue":"5","key":"10.1007\/s13311-013-0255-9_bib20","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/hmg\/ddn419","article-title":"17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse","volume":"18","author":"Tokui","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"46","key":"10.1007\/s13311-013-0255-9_bib21","doi-asserted-by":"crossref","first-page":"16801","DOI":"10.1073\/pnas.0506249102","article-title":"Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease","volume":"102","author":"Katsuno","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1007\/s13311-013-0255-9_bib22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10637-006-9208-z","article-title":"A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma","volume":"24","author":"Ronnen","year":"2006","journal-title":"Invest New Drugs"},{"issue":"2","key":"10.1007\/s13311-013-0255-9_bib23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00280-004-0947-2","article-title":"Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models","volume":"56","author":"Smith","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10.1007\/s13311-013-0255-9_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00280-001-0380-8","article-title":"Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats","volume":"49","author":"Egorin","year":"2002","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10.1007\/s13311-013-0255-9_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.b.30777","article-title":"Criteria for validating mouse models of psychiatric diseases","volume":"150B","author":"Chadman","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"2","key":"10.1007\/s13311-013-0255-9_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pneurobio.2011.11.006","article-title":"Toward understanding Machado-Joseph disease","volume":"97","author":"Costa Mdo","year":"2012","journal-title":"Prog Neurobiol."},{"issue":"28","key":"10.1007\/s13311-013-0255-9_bib27","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1523\/JNEUROSCI.4540-06.2007","article-title":"Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence","volume":"27","author":"Bichelmeier","year":"2007","journal-title":"J Neurosci"},{"issue":"9","key":"10.1007\/s13311-013-0255-9_bib28","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/11.9.1075","article-title":"YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit","volume":"11","author":"Cemal","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1007\/s13311-013-0255-9_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2008.03.011","article-title":"Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation","volume":"31","author":"Chou","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"45","key":"10.1007\/s13311-013-0255-9_bib30","doi-asserted-by":"crossref","first-page":"10266","DOI":"10.1523\/JNEUROSCI.2734-04.2004","article-title":"A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration","volume":"24","author":"Goti","year":"2004","journal-title":"J Neurosci"},{"issue":"1","key":"10.1007\/s13311-013-0255-9_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2010.05.021","article-title":"Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products","volume":"40","author":"Silva-Fernandes","year":"2010","journal-title":"Neurobiol Dis"},{"issue":"15","key":"10.1007\/s13311-013-0255-9_bib32","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1093\/hmg\/ddr203","article-title":"Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1 pathways","volume":"20","author":"Teixeira-Castro","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1007\/s13311-013-0255-9_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00280-004-0939-2","article-title":"In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative","volume":"56","author":"Hollingshead","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1007\/s13311-013-0255-9_bib34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0065-2660(08)60361-2","article-title":"Genetic factors in aging","volume":"16","author":"Curtis","year":"1971","journal-title":"Adv Genet."},{"issue":"11","key":"10.1007\/s13311-013-0255-9_bib35","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.leukres.2010.07.002","article-title":"Autophagy inhibition sensitizes multiple myeloma cells to 17-dimethylaminoethylamino-17-demethoxygeldanamycin-induced apoptosis","volume":"34","author":"Palacios","year":"2010","journal-title":"Leuk Res"},{"issue":"1","key":"10.1007\/s13311-013-0255-9_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2010.08.023","article-title":"17-AAG increases autophagic removal of mutant androgen receptor in spinal and bulbar muscular atrophy","volume":"41","author":"Rusmini","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1007\/s13311-013-0255-9_bib37","doi-asserted-by":"crossref","first-page":"e8753","DOI":"10.1371\/journal.pone.0008753","article-title":"17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy","volume":"5","author":"Riedel","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1007\/s13311-013-0255-9_bib38","doi-asserted-by":"crossref","first-page":"e13695","DOI":"10.1371\/journal.pone.0013695","article-title":"Splice isoforms of the polyglutamine disease protein ataxin-3 exhibit similar enzymatic yet different aggregation properties","volume":"5","author":"Harris","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1007\/s13311-013-0255-9_bib39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1750-3639.2006.00022.x","article-title":"Spinocerebellar ataxia type 3 (SCA3): thalamic neurodegeneration occurs independently from thalamic ataxin-3 immunopositive neuronal intranuclear inclusions","volume":"16","author":"Rub","year":"2006","journal-title":"Brain Pathol"},{"issue":"2","key":"10.1007\/s13311-013-0255-9_bib40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.nbd.2009.08.002","article-title":"A transgenic mouse model of spinocerebellar ataxia type 3 resembling late disease onset and gender-specific instability of CAG repeats","volume":"37","author":"Boy","year":"2010","journal-title":"Neurobiol Dis"},{"issue":"2\u20133","key":"10.1007\/s13311-013-0255-9_bib41","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000101849","article-title":"Small molecule inducers of heat-shock response reduce polyQ-mediated huntingtin aggregation. A possible therapeutic strategy","volume":"4","author":"Herbst","year":"2007","journal-title":"Neurodegener Dis"},{"issue":"8","key":"10.1007\/s13311-013-0255-9_bib42","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1172\/JCI57413","article-title":"Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease","volume":"121","author":"Labbadia","year":"2011","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1007\/s13311-013-0255-9_bib43","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrm2938","article-title":"Heat shock factors: integrators of cell stress, development and lifespan","volume":"11","author":"Akerfelt","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"10.1007\/s13311-013-0255-9_bib44","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1200\/JCO.2009.25.0415","article-title":"Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors","volume":"28","author":"Ramanathan","year":"2010","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1007\/s13311-013-0255-9_bib45","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1101\/gad.6.8.1402","article-title":"The consequences of expressing hsp70 in Drosophila cells at normal temperatures","volume":"6","author":"Feder","year":"1992","journal-title":"Genes Dev"},{"issue":"1","key":"10.1007\/s13311-013-0255-9_bib46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1258\/0023677021911740","article-title":"Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units","volume":"36","author":"Nicklas","year":"2002","journal-title":"Lab Anim"},{"issue":"8","key":"10.1007\/s13311-013-0255-9_bib47","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J Neurosci"},{"issue":"1","key":"10.1007\/s13311-013-0255-9_bib48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J Neurosci Methods"},{"issue":"11","key":"10.1007\/s13311-013-0255-9_bib49","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1523\/JNEUROSCI.4372-06.2007","article-title":"The prefrontal cortex as a key target of the maladaptive response to stress","volume":"27","author":"Cerqueira","year":"2007","journal-title":"J Neurosci"},{"issue":"11","key":"10.1007\/s13311-013-0255-9_bib50","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbamcr.2007.07.012","article-title":"NEDD8: a new ataxin-3 interactor","volume":"1773","author":"Ferro","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1007\/s13311-013-0255-9_bib51","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1699-0463.1988.tb05320.x","article-title":"Some new, simple and efficient stereological methods and their use in pathological research and diagnosis","volume":"96","author":"Gundersen","year":"1988","journal-title":"APMIS"},{"issue":"4","key":"10.1007\/s13311-013-0255-9_bib52","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ar.1092310411","article-title":"Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator","volume":"231","author":"West","year":"1991","journal-title":"Anat Rec"},{"key":"10.1007\/s13311-013-0255-9_bib53","unstructured":"Zar JH. Biostatistical Analysis, 4th edn. Prentice Hall, 1999."}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-013-0255-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-013-0255-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923009108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923009108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-013-0255-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:45:34Z","timestamp":1761806734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923009108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1878747923009108"],"URL":"https:\/\/doi.org\/10.1007\/s13311-013-0255-9","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Treatment with 17-DMAG Improves Balance and Coordination in A New Mouse Model of Machado-Joseph Disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-013-0255-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}